(Q42663264)

4 November 2017

0 references

Personalized medicine and inhibition of EGFR signaling in lung cancer (English)

1 reference

4 November 2017

personalized medicine

1 reference

1 reference

Adi F Gazdar

1 reference

PMC publication ID

3390194

4 November 2017

language of work or name

English

0 references

publication date

19 August 2009

1 reference

The New England Journal of Medicine

4 November 2017

1 reference

4 November 2017

361

1 reference

4 November 2017

1 reference

4 November 2017

1018-1020

1 reference

Screening for epidermal growth factor receptor mutations in lung cancer

4 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3390194

Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3390194

Alterations in genes of the EGFR signaling pathway and their relationship to EGFR tyrosine kinase inhibitor sensitivity in lung cancer cell lines

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3390194

The epidermal growth factor receptor: a role in repair of radiation-induced DNA damage

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3390194

Epidermal growth factor receptor mutations in lung cancer

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3390194

Erlotinib in previously treated non-small-cell lung cancer

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3390194

27 May 2018

The Hallmarks of Cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3390194

Toward noninvasive genomic screening of lung cancer patients.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3390194

Unraveling the mystery of prognostic and predictive factors in epidermal growth factor receptor therapy

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3390194

Increased HER2 gene copy number is associated with response to gefitinib therapy in epidermal growth factor receptor-positive non-small-cell lung cancer patients

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3390194

16 August 2018

Identifiers

DOI

10.1056/NEJME0905763

1 reference

4 November 2017

1 reference

PMC publication ID

3390194

4 November 2017

PubMed publication ID

19692681

1 reference

PMC publication ID

3390194